About 9% of adults hospitalized with RSV died in the hospital or within 30 days of discharge, according to preliminary data ...
The Sydney scientist who was a colleague of the late Professor Richard Scolyer was a driving force behind the breakthrough ...
Experimental personalized cancer vaccines made with mRNA and some other approaches also are being tested against other types ...
A personalised mRNA cancer vaccine, used alongside an existing immunotherapy drug, has been linked to a 42 percent reduction ...
When the news arrived in August that what could be the first personalized mRNA cancer vaccine had succeeded in a late-stage ...
The data were not bad — in fact, the outcome was better than many analysts had predicted. The problem was Cambridge-based ...
A needle-free vaccination method protected mice against the viruses that cause COVID-19 and flu, offering a possible new way ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results